| Income Statement |
| Total Revenue | 433.38M |
|
| Revenues (USD) | 60.28M |
| Cost of Revenue | 329.13M |
| Gross Profit | 104.25M |
| Operating Expenses | 153.68M |
| Research and Development Expense | 55.42M |
| Selling, General and Administrative Expense | 104.92M |
| Operating Income | -49.43M |
| Interest Expense | 1.34M |
| Income Tax Expense | 1.73M |
| Net Income | -40.13M |
| Net Income Common Stock | -40.13M |
| Net Income Common Stock (USD) | -5.58M |
| Consolidated Income | -42.62M |
| Net Income to Non-Controlling Interests | 2.49M |
| Earnings per Basic Share | -0.90 |
| Earnings per Basic Share (USD) | -0.12 |
| Earnings per Diluted Share | -0.90 |
| Earning Before Interest & Taxes (EBIT) | -37.07M |
| Earning Before Interest & Taxes (USD) | -5.16M |
| Weighted Average Shares | 1.09B |
| Balance Sheet |
| Cash and Equivalents | 1.18B |
| Cash and Equivalents (USD) | 164.00M |
| Investments | 1.09B |
| Investments Current | 1.08B |
| Investments Non-Current | 7.83M |
| Trade and Non-Trade Receivables | 849.64M |
| Current Assets | 3.16B |
| Property, Plant & Equipment Net | 45.21M |
| Total Assets | 3.73B |
| Debt Current | 20.66M |
| Total Debt | 20.66M |
| Current Liabilities | 1.29B |
| Total Liabilities | 1.32B |
| Accumulated Retained Earnings (Deficit) | -8.41B |
| Shareholders Equity | 2.47B |
| Shareholders Equity (USD) | 343.49M |
| Assets Non-Current | 568.45M |
| Total Debt (USD) | 2.87M |
| Deferred Revenue | 131.58M |
| Goodwill and Intangible Assets | 182.56M |
| Liabilities Non-Current | 27.38M |
| Trade and Non-Trade Payables | 927.61M |
| Tax Assets | 313.81M |
| Cash Flow |
| Net Cash Flow from Financing | -9.91M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -538.36M |
| Net Cash Flow from Investing | -508.45M |
| Net Cash Flow from Operations | -20.00M |
| Effect of Exchange Rate Changes on Cash | -1.56M |